Metabolomics 2018 (Corporate License)
Published March 2018
Over the past five years, the market for metabolomics has increased dramatically, with LC/MS and NMR leading the charge in the areas of biomarker discovery, phenotyping, toxicology and clinical/ diagnostics research. Demand for instruments continues to be robust, particularly with metabolomics scientists perpetually seeking next generation technologies and methods. This report on metabolomics uncovers the new challenges and opportunities of the market for the next five years.